Tutt, A., Tovey, H., Cheang, M. C. U., Kernaghan, S., Kilburn, L., Gazinska, P., . . . Bliss, J. M. (2018). A randomised phase III trial of carboplatin compared with docetaxel in BRCA1/2 mutated and pre-specified triple negative breast cancer “BRCAness” subgroups: The TNT Trial. Nat Med.
Citação norma ChicagoTutt, Andrew, et al. "A Randomised Phase III Trial of Carboplatin Compared With Docetaxel in BRCA1/2 Mutated and Pre-specified Triple Negative Breast Cancer “BRCAness” Subgroups: The TNT Trial." Nat Med 2018.
Citação norma MLATutt, Andrew, et al. "A Randomised Phase III Trial of Carboplatin Compared With Docetaxel in BRCA1/2 Mutated and Pre-specified Triple Negative Breast Cancer “BRCAness” Subgroups: The TNT Trial." Nat Med 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.